Skip to main navigation Skip to search Skip to main content

Zydus announces phase-IV Dream-CKD trial to generate real-world evidence of Desidustat in patients with CKD-induced anaemia

Press/Media

Period31 Aug 2022

Media coverage

2

Media coverage